Claudia Vener

Treatment of refractory chronic GVHD with rituximab: a GITMO study

Francesco Zaja, Andrea Bacigalupo, Francesca Patriarca et al. · Bone Marrow Transplantation · 2007 · 169 citations · Full text

Immunology, Treatment Option, Pharmacotherapy +2

Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

Laura Botta, Gemma Gatta, Riccardo Capocaccia et al. · The Lancet Oncology · 2022 · 167 citations · Full text

Cure Fraction Estimates, Cancer Epidemiology, Childhood Cancer +9

The European Consensus on grading of bone marrow fibrosis allows a better prognostication of patients with primary myelofibrosis

Umberto Gianelli, Claudia Vener, Anna Bossi et al. · Modern Pathology · 2012 · 128 citations · Full text

Hematological Malignancy, Bone Marrow Failure, Bone Marrow Fibrosis +9

Risk of hepatitis B surface antigen seroreversion after allogeneic hematopoietic SCT

Mauro Viganò, Claudia Vener, Pietro Lampertico et al. · Bone Marrow Transplantation · 2010 · 99 citations

Vaccination, Viral Hepatitis, Immunology +6

Complete cancer prevalence in Europe in 2020 by disease duration and country (EUROCARE-6): a population-based study

Roberta De Angelis, Elena Demuru, Paolo Baili et al. · The Lancet Oncology · 2024 · 95 citations · Full text

Disease Duration, Epidemiology, Population-based Study +13